The inhibition of Candida albicans secreted aspartyl proteinase by triangular gold nanoparticles

Objective(s): The aim of this study was to synthesize triangular gold nanoparticles, and then to evaluate their capability for inhibition of Candida albicans secreted aspartyl proteinase 2(Sap2). Materials and Methods: To synthesize the nanoparticles, hydrogen tetrachloroaurate and hexadecyl trimeth...

Full description

Bibliographic Details
Published in:	Nanomedicine Journal
Main Authors:	Farzaneh Haji Esmaeil Hajjar, Ali Jebali, Seyedhossein Hekmatimoghaddam
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2015-01-01
Subjects:	Candida albicans Peptide ligand Secreted aspartyl proteinase Triangular gold nanoparticles
Online Access:	http://nmj.mums.ac.ir/pdf_3469_2c9dfb42ef4f6d96540623e1c5a151c4.html

Similar Items

The effects of secreted aspartyl proteinase inhibitor ritonavir on azoles‐resistant strains of Candida albicans as well as regulatory role of SAP2 and ERG11
by: Wenli Feng, et al.
Published: (2021-09-01)

Antifungal potential of the main compounds of Cuminum cyminum L. in targeting secreted aspartyl proteinase of Candida albicans compared to fluconazole
by: Azizeh Asadzadeh, et al.
Published: (2024-08-01)

Genotypic Patterns of Secreted Aspartyl Proteinase Gene in Various Candida Species Isolated from Antenatal Women with Vulvovaginal Candidiasis
by: Kanishka Hrishi Das, et al.
Published: (2019-06-01)

Biofilm Formation and Aspartyl Proteinase Activity and Their Association with Azole Resistance Among Candida albicans Causing Vulvovaginal Candidiasis, Egypt
by: Gerges MA, et al.
Published: (2023-08-01)

Molecular docking analysis of Cinnamomum zeylanicum phytochemicals against Secreted Aspartyl Proteinase 4–6 of Candida albicans as anti-candidiasis oral
by: Vita Meylani, et al.
Published: (2023-01-01)

Candida albicans proteinases
by: Rita de Cássia Mardegan, et al.
Published: (2015-11-01)

Biofilm, proteinase and phospholipase production by Candida albicans isolates from a hospital in Thailand
by: Srisuda Pannanusorn, et al.
Published: (2023-12-01)

antibacterial activity of candida albicans aspartly proteinase
by: AZHARA. Ibrahim, et al.
Published: (2005-10-01)

Therapeutic implications of candida phenotypes, virulence factors and antifungal sensitivity in Oral leukoplakia
by: Shalini R. Gupta, et al.
Published: (2021-04-01)

Investigation of the relationship between fluconazole susceptibility, proteinase activity and ERG11-SAP2 Expression in Candida albicans strains isolated from clinical samples
by: Nagihan Ege, et al.
Published: (2024-12-01)

Cell progression of biofilm formation in Candida albicans and estimation of aspartic proteinase activity
by: Rowida Ghareb Elshazly, et al.
Published: (2022-12-01)

Investigating the presence of phospholipase and secreted aspartyle proteinase gene family in different genotypes of Candida albicans species
by: Mozhgan Mahmoodi, et al.
Published: (2025-10-01)

Contribution of N-Linked Mannosylation Pathway to Candida parapsilosis and Candida tropicalis Biofilm Formation
by: Clavijo-Giraldo DM, et al.
Published: (2023-10-01)

Functionality of the human antibody response to Candida albicans
by: Melissa Wich, et al.
Published: (2021-12-01)

Estimating the expression levels of genes controlling biofilm formation and evaluating the effects of different conditions on biofilm formation and secreted aspartic proteinase activity in Candida albicans and Saccharomyces cerevisiae: a comparative study
by: Shaimaa S. Sobieh, et al.
Published: (2024-05-01)

Secreted aspartyl protease 3 regulated by the Ras/cAMP/PKA pathway promotes the virulence of Candida auris
by: Ji-Seok Kim, et al.
Published: (2023-09-01)

Phylogeny and evolution of the aspartyl protease family from clinically relevant Candida species
by: B Parra-Ortega, et al.
Published: (2009-05-01)

2,4-Diacetylphloroglucinol Modulates <i>Candida albicans</i> Virulence
by: Artyom A. Stepanov, et al.
Published: (2022-09-01)

Virtual screening assisted identification of a phytocompound as potent inhibitor against Candida lusitaniae; an in-silico study
by: Rimsha Timotheous, et al.
Published: (2025-01-01)

Candida parapsilosis Characterization in an Outbreak Setting
by: Duncan M. Kuhn, et al.
Published: (2004-06-01)

In vitro differential activity of phospholipases and acid proteinases of clinical isolates of Candida
by: Aurean D'Eça Júnior, et al.
Published: (2011-06-01)

Molecular Docking of Thymus Vulgaris Biochemical Against Candida Albicans Secreted Aspartyl Protease 5 to Find Possible Inhibitory Compounds
by: M Zare, et al.
Published: (2024-07-01)

Distribution of Candida albicans and Non-albicans Candida Species Causing Vaginitis in Iran: A Review
by: OmeFarveh Rostami, et al.
Published: (2025-04-01)

PEMERIKSAAN MIKROBIOLOGI PADA CANDIDA ALBICANS
by: Vivi Keumala Mutiawati
Published: (2016-04-01)

DIFFERENTIAL EXPRESSION OF SECRETED ASPARTYL PROTEASE (SAP8 AND SAP10) GENES AND COMPARATIVE PATHOGENICITY OF Candida albicans GROWN IN VARIOUS ENVIRONMENTAL CONDITIONS
by: Inas K. Rahem, et al.
Published: (2020-11-01)

Candida albicans END3 Mediates Endocytosis and Has Subsequent Roles in Cell Wall Integrity, Morphological Switching, and Tissue Invasion
by: Christiane Rollenhagen, et al.
Published: (2022-04-01)

Proteinase-Activated Receptors of Digestive Systems
by: G. F. Korotko
Published: (2012-03-01)

Biochemical characterization of cathepsin D from adult Schistosoma mansoni worms
by: Italo M Cesari, et al.
Published: (1998-01-01)

Epithelial effects of proteinase-activated receptors in the gastrointestinal tract
by: Wallace K MacNaughton
Published: (2005-03-01)

Candida albicans skin abscess Abscesso de pele por Candida albicans
by: Felipe Francisco Tuon, et al.
Published: (2006-10-01)

Candida albicans aspartyl protease (Sap6) inhibits neutrophil function via a “Trojan horse” mechanism
by: Marcin Zawrotniak, et al.
Published: (2025-02-01)

Evaluation of Diverse Phenotypic Methods for Differenting between Candida dubliniensis and Candida albicans
by: Dayana Camacho, et al.
Published: (2012-01-01)

Candidemia – Changing trends from Candida albicans to non-albicans Candida from a tertiary care center in western UP, India
by: Shariq Ahmed, et al.
Published: (2020-01-01)

COMPARISON OF TWO METHODS OR DETECTION OF SECRETED ASPARTYL PROTEINASE IN URINARY ISOLATES OF CANDIDA SPECIES
by: Santosh Patil, et al.
Published: (2014-06-01)

Espondilodiscitis por Candida albicans Candida albicans spondylodiscitis: Diagnosis and Treatment
by: Silvina De Luca, et al.
Published: (2008-03-01)

Immune response to Candida albicans <br> Resposta imune a Candida albicans
by: Luis Carlos Jabur Gaziri, et al.
Published: (2008-10-01)

Plasmepsin-like Aspartyl Proteases in <i>Babesia</i>
by: Pavla Šnebergerová, et al.
Published: (2021-09-01)

Transcriptomic insights into Candida albicans adaptation to an anaerobic environment
by: Karen D. Zeise, et al.
Published: (2025-07-01)

Serotyping of Candida albicans isolated from clinical specimens
by: Maria L. Martinez Batista, et al.
Published: (1990-03-01)

Glucose Tolerance in Pregnant Women Inflicted with Candida Albicans
by: Tarik Hovthy A.T. AL-Khayat, et al.
Published: (2009-06-01)